Ameritas Investment Company, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Company, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$172,000
+36.5%
44,232
+12.7%
0.01%
+33.3%
Q2 2021$126,000
+425.0%
39,232
+263.9%
0.01%
+20.0%
Q4 2020$24,000
-27.3%
10,7820.0%0.01%
-50.0%
Q3 2020$33,0000.0%10,7820.0%0.01%
+11.1%
Q2 2020$33,000
+32.0%
10,782
-18.8%
0.01%
+125.0%
Q1 2020$25,000
-19.4%
13,282
+23.2%
0.00%
-42.9%
Q4 2019$31,00010,7820.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders